IL2 and influenza: In any case, despite the putative adverse effects of IL-2, treatment with low-dose rIL-2 and IL-2/anti-IL-2 Ab complexes efficiently decreases anti-DNA Ab titers in NZB/W F1 mice (189) and hinders influenza-specific B cell responses in influenza-infected mice (114).